GoHealth, Inc. (NASDAQ:GOCO) Sees Large Increase in Short Interest

GoHealth, Inc. (NASDAQ:GOCO - Get Free Report) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 223,400 shares, a growth of 8.9% from the March 15th total of 205,100 shares. Based on an average daily volume of 15,000 shares, the short-interest ratio is presently 14.9 days. Currently, 3.0% of the company's shares are sold short.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada decreased their price target on shares of GoHealth from $20.00 to $13.00 and set a "sector perform" rating on the stock in a research note on Wednesday, March 20th.

View Our Latest Stock Analysis on GOCO

GoHealth Trading Up 6.5 %

Shares of GoHealth stock traded up $0.62 during mid-day trading on Monday, hitting $10.15. 16,441 shares of the stock were exchanged, compared to its average volume of 15,158. The company has a 50-day simple moving average of $11.82 and a 200 day simple moving average of $12.87. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 1.54. GoHealth has a twelve month low of $7.05 and a twelve month high of $22.85. The stock has a market capitalization of $228.17 million, a price-to-earnings ratio of -1.42 and a beta of 1.80.


GoHealth (NASDAQ:GOCO - Get Free Report) last released its earnings results on Thursday, March 14th. The company reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.73 by ($2.13). GoHealth had a negative return on equity of 9.29% and a negative net margin of 8.61%. The company had revenue of $276.70 million during the quarter, compared to analyst estimates of $362.38 million. Research analysts forecast that GoHealth will post -5.22 EPS for the current year.

Institutional Investors Weigh In On GoHealth

Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. raised its holdings in GoHealth by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 200,920 shares of the company's stock valued at $2,680,000 after buying an additional 2,644 shares during the period. Barclays PLC raised its holdings in GoHealth by 114.3% in the fourth quarter. Barclays PLC now owns 9,334 shares of the company's stock valued at $125,000 after buying an additional 4,978 shares during the period. Bridgeway Capital Management LLC raised its holdings in GoHealth by 9.3% in the fourth quarter. Bridgeway Capital Management LLC now owns 18,136 shares of the company's stock valued at $242,000 after buying an additional 1,536 shares during the period. Northern Trust Corp raised its holdings in GoHealth by 23.2% in the fourth quarter. Northern Trust Corp now owns 39,995 shares of the company's stock valued at $534,000 after buying an additional 7,526 shares during the period. Finally, Associated Banc Corp purchased a new position in GoHealth in the fourth quarter valued at approximately $257,000. 24.21% of the stock is owned by institutional investors and hedge funds.

About GoHealth

(Get Free Report)

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ $5,000 Gold? (From Stansberry Research) (Ad)

Should you invest $1,000 in GoHealth right now?

Before you consider GoHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.

While GoHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

Search Headlines: